Effects of the antiestrogen tamoxiten on low-density lipoprotein concentrations and oxidation in postmenopausal women

Victor Guetta*, Richard M. Lush, William D. Figg, Myron A. Waclawiw, Richard O. Cannon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

Our study demonstrates that tamoxifen, when administered to postmenopausal women at a conventional dosage, reduces LDL levels and protects LDL from oxidation. The protective effect of tamoxifen against the development of breast cancer in women considered at risk is being investigated in a placebo-controlled trial sponsored by the National Institutes of Health. Whether tamoxifen also protects against the development of cardiovascular disease in this trial is also of considerable interest.

Original languageEnglish
Pages (from-to)1072-1073
Number of pages2
JournalThe American Journal of Cardiology
Volume76
Issue number14
DOIs
StatePublished - 15 Nov 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Effects of the antiestrogen tamoxiten on low-density lipoprotein concentrations and oxidation in postmenopausal women'. Together they form a unique fingerprint.

Cite this